New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

People with serious mental illness have higher rates of overweight and obesity, and obesity-related illnesses can worsen psychiatric symptoms. A 6-month fully remote weight-loss program tailored to ...

Lilly says weight-loss pill meets three out of four criteria for FDA commissioner voucher International Mounjaro sales exceed estimates by nearly $1 billion Third-quarter beat reinforces Lilly lead in ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal ...

Weight loss can seem like it comes with a list of dos and don’ts, making it overwhelming. Cardio is a particularly hot topic amongst weight loss experts, and if we’re being honest, the constant ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE Featured Partner While Ozempic has been ...